Literature DB >> 1980493

Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.

H Shibata1, R Kanamaru, T Sato, C Ishioka, Y Konishi, A Ishikawa, A Wakui, T Tsuruo.   

Abstract

We examined the effect of hemin, sodium butyrate and mitomycin C on levels of P-glycoprotein mRNA in human myelogenous K562 cells by northern blot analysis. After treatment with sodium butyrate a dose-dependent increase of P-glycoprotein mRNA expression was observed in the adriamycin-resistant K562 and vincristine-resistant K562 lines. With 10 mM sodium butyrate, the level of P-glycoprotein mRNA reached 20 times that of control adriamycin-resistant K562 and with 30 mM sodium butyrate, it exceeded 5 times that of control vincristine-resistant K562. In contrast, hemin and mitomycin C had almost no effect on P-glycoprotein mRNA. In this experiment, since expression of P-glycoprotein mRNA was not necessarily accompanied with induction of erythroid differentiation, the increased amount of P-glycoprotein mRNA is unlikely to be a result of differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980493      PMCID: PMC5918010          DOI: 10.1111/j.1349-7006.1990.tb02681.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.

Authors:  T Tsuruo; H Iida-Saito; H Kawabata; T Oh-hara; H Hamada; T Utakoji
Journal:  Jpn J Cancer Res       Date:  1986-07

2.  Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.

Authors:  H Hamada; E Okochi; T Oh-hara; T Tsuruo
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

3.  Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.

Authors:  L J Wilkoff; E A Dulmadge
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

4.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.

Authors:  I B Roninson; H T Abelson; D E Housman; N Howell; A Varshavsky
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

5.  Inducers of erythroid differentiation in K562 human leukemia cells.

Authors:  P T Rowley; B M Ohlsson-Wilhelm; B A Farley; S LaBella
Journal:  Exp Hematol       Date:  1981-01       Impact factor: 3.084

6.  Establishment and properties of vincristine-resistant human myelogenous leukemia K562.

Authors:  T Tsuruo; H Iida; E Ohkochi; S Tsukagoshi; Y Sakurai
Journal:  Gan       Date:  1983-10

7.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

8.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.

Authors:  A R Safa; C J Glover; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

9.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

10.  Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

Authors:  I B Roninson; J E Chin; K G Choi; P Gros; D E Housman; A Fojo; D W Shen; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more
  1 in total

1.  Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cells.

Authors:  Nobuaki Shiraki; Keiko Okamura; Jin Tokunaga; Takafumi Ohmura; Kazuto Yasuda; Takeo Kawaguchi; Akinobu Hamada; Masahiro Nakano
Journal:  Jpn J Cancer Res       Date:  2002-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.